Pharmaceutical manufacturers of Teneligliptin

Lee Pharma Limited was established in 1997 in India it is a research-driven company with a critical focus on the development, synthesis, and commercialization of new products and cost-effective processes. ​ We manufacture several intermediate chemicals, Active Pharmaceutical Ingredients & Semi-finished Dosage Forms (Pellets & Granules), and Finished Formulations. Our expertise in the field won us, numerous clients, in India as well as across the globe. Lee Pharma Manufacturing facilities are approved by several international regulatory bodies such as USFDA, EUGMP, WHO GMP etc.

Granules India Limited is a rapidly expanding pharmaceutical company with top-notch amenities for APIs, PFIs and Finished Dosages, catering to clients in more than 60 nations. We are dedicated to upholding high standards in production, excellence and client relations. Our main office is situated in Hyderabad, and we also have branches in the United States, United Kingdom, Colombia and China, as well as production facilities in India and China.

Ami Lifesciences, established in 2006, is one of the fastest growing Active Pharmaceutical Ingredient (API) manufacturing companies in India, meeting unmet patient needs in various therapeutic areas such as Cardiovascular, Anti-Diabetics, CNS, and Respiratory amongst other categories, produced From Manufacturing unit located in Vadodara, Gujarat. We are recognised as a reliable supplier of generic APIs and a trustworthy Contract Development & Manufacturing partner for generic, Big Pharma & innovator pharmaceutical companies worldwide. We are among the leading manufacturers of APIs, intermediates and registered Key Starting Materials offering quality products with highest quality compliance & integrity to over 60+ countries. We believe, unlocking early launch opportunities, being cost competitive by virtue of backward integration and offering complete supply chain assurance is key to enable our customers to succeed & sustain their products through the product life cycle over a period of time.

We have more than 20 years of experience providing a range of contract research, development and manufacturing services across the drug development continuum, with a focus on early-stage discovery and development of new molecular entities (NMEs). Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement.

Kukjeon Pharmaceutical has been actively contributing to the advancement of South Korea's pharmaceutical industry by supplying active pharmaceutical ingredients (API) developed through 50 years of professional capacity building. Currently, we provide API to more than 200 pharmaceutical and electronics companies domestically and internationally. We are a comprehensive chemical solution provider offering a wide range of chemical-based products and services, supported by an organizational system and the capability to engage in research and development as well as foundational businesses.

Kimia Biosciences, established in 1993, specializes in the production of bulk drugs for various medical segments. With a strong focus on quality and advanced technologies, Kimia aims to achieve global recognition in the production of both APIs and FDFs, while maintaining ethical business practices. The state-of-the-art facilities at Village Bhondsi, Gurugram enable the production of a wide range of APIs. Additionally, Kimia plans to develop its own facilities for lifestyle segments, adhering to international regulatory standards, with the goal of delivering top-quality pharmaceutical products and support to both consumers and healthcare professionals.

Smruthi Organics Ltd operates as an active pharmaceutical ingredient (API) manufacturing firm located in the country of India. With more than three decades of experience, we have been providing API to pharmaceutical firms worldwide. Our commitment to delivering top-notch API at competitive prices and within the set timelines has solidified our position as a key manufacturer of anti-diabetes, anti-hypertension, anti-platelet, and anti-infective API in India. Additionally, our API manufacturing facility holds GMP certification. Our proficient team of QA & Regulatory Affairs experts extends unparalleled technical and documentation support globally. Furthermore, we are publicly listed on the Bombay Stock Exchange (BSE).

KyungDong Pharm is making progress on a global scale. Established in 1975, KyungDong Pharm has been dedicated to developing ethical medicines and creating its own technologies for medicine development, previously reliant on imports. With the belief of leading human health and happiness through sincere and diligent efforts in medicine creation and development, the company has been actively involved in research and development. Currently, it contributes to the health of the Korean population by producing approximately 90 types of ethical medicines, pharmaceutical ingredient medicine, and non-prescription medicine.

Ever since its establishment in 2000, Pharmacostech has played a prominent role in the fine chemical industry. The company has cultivated fundamental technologies, optimized manufacturing processes, and harnessed new discoveries from both internal and external laboratories. This includes the synthesis of novel chemicals and the development of environmentally-friendly processes, which have been successfully commercialized. In 2005, they commissioned a state-of-the-art GMP factory in Hwaseong, Gyeonggido, building upon their advanced technology. Today, Pharmacostech is embarking on its next challenge as a leading API producer.

Epoch-Labs, a research organization based in Hyderabad, India, offers scientific services to large pharmaceutical and agrochemical companies worldwide to expedite their R&D programs from discovery to production. With a focus on research and customer satisfaction, Epoch-Labs provides services aimed at reducing the discovery and development time through cost-effective and efficient outsourcing solutions for our clients.